Non‐severe COVID‐19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis

BACKGROUND: Hypercoagulability and endothelial dysfunction are hallmarks of coronavirus disease 2019 (COVID‐19) and appear to predict disease severity. A high incidence of thrombosis despite thromboprophylaxis is reported in patients with moderate to severe COVID‐19. Recent randomized clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelliher, Sarah, Weiss, Luisa, Cullivan, Sarah, O’Rourke, Ellen, Murphy, Claire A., Toolan, Shane, Lennon, Áine, Szklanna, Paulina B., Comer, Shane P., Macleod, Hayley, Le Chevillier, Ana, Gaine, Sean, O’Reilly, Kate M.A., McCullagh, Brian, Stack, John, Maguire, Patricia B., Ní Áinle, Fionnuala, Kevane, Barry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305123/
https://www.ncbi.nlm.nih.gov/pubmed/35102689
http://dx.doi.org/10.1111/jth.15660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305123/
https://www.ncbi.nlm.nih.gov/pubmed/35102689
http://dx.doi.org/10.1111/jth.15660

Ejemplares similares